S&P 5007,785.76▼0.2% Nasdaq26,729.16▼0.3% Dow53,732.41▼0.2% Russell 2K3,068.42▲0.5% 10-Yr4.70%+6bp VIX14.25−0.38 WTI$82.40▲1.4% Gold$4,432.00▲1.6% EUR/USD1.157▲0.4% BTC$65,606▲1.4% Nikkei68,309▲1.2%
At close · Fri, Aug 14, 2026
Daily Market Updates.

US Markets

Home›US Markets›Sectors›Moderna jumps after promising cancer vaccine results,…

Moderna jumps after promising cancer vaccine results, investors weigh profit-taking

Reported · Written up by our desk · Sectors

CNBC Markets highlighted a set of key factors investors may watch in the stock market on Wednesday, with Moderna and Target among the names in focus.

The outlet said Moderna was rising sharply after promising results for its cancer vaccine.

CNBC Markets also noted Target could be a target for profit-taking, implying near-term selling pressure following prior moves.

← Newer storyTarget reports stronger sales and lifts full-year outlook

More like this

US MarketsQuanta Services highlighted as AI power demand beneficiary
US MarketsBerkshire pushes into housing, while home-builder timing remains hard
US MarketsMonzo users face card payment and transfer outages
US Markets15 S&P 500 stocks have doubled or more in 2026, led by memory chip demand
US MarketsAI revenue growth worries weigh on tech stocks premarket

Sources

CNBC MarketsJim Cramer's top 10 things to watch in the stock market Wednesday

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.